학술논문
PS024 - Sofosbuvir/Velpatasvir in Combination with Ribavirin for 24 Weeks is Effective Retreatment for Patients who failed Prior NS5A Containing DAA Regimens: Results of the GS-US-342-1553 Study
Document Type
Abstract
Author
Source
In Journal of Hepatology 2016 64(2) Supplement:S147-S148
Subject
Language
ISSN
0168-8278